NCT02125500View on ClinicalTrials.gov

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Viral Hepatitis CHIV

Interventions

DRUG

Sofosbuvir/Ledipasvir fixed dose

SOF 400 mg/LDV 90 mg FDC tablet administered orally once daily

Trial Locations (1)

Unknown

Centre de Méthodologie et de Gestion de Rennes, Rennes

All Listed Sponsors

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT02125500 - Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection | Biotech Hunter | Biotech Hunter